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Abstract
Strokes are the fifth leading cause of death in the United States and can
cause long-term disabilities in patients who survive a stroke. The vast majority
of these strokes are ischemic, primarily caused by intracranial atherosclerosis.
Most therapies to combat intracranial atherosclerosis simply manage it and do
not remove the buildup of plaque. Targeted shear-activated nanotherapeutics
are currently being developed to remove these plaques. We discuss the roles
that aggregate particle density, aggregate particle diameter, vessel geometry,
stenosis shape and breakup threshold play in the efficiency of this new technol-
ogy. Computational studies were performed to test these parameters in three
idealized vessels with varying curvatures (straight, quarter-circle, semi-circle)
and two different stenosis shapes (concentric, eccentric). We find that curvature
plays a large role in the breakup threshold. The optimal breakup threshold for
a semi-circular shaped vessel is 4.5 times that of a straight vessel, yet the less
curved quarter-circle shaped vessel has an optimal breakup threshold that is
6.3 times that of the straight vessel. Therefore, no quantifiable pattern was dis-
covered between geometry curvature and optimal threshold value. Curvature
also plays a large role in how particle diameter affects the efficiency of these
nanotherapeutics. Although the effects of particle size between 1 and 5 μm is
minimal, the optimal particle diameter for a straight vessel was located at the
smallest end of the tested range while the optimal diameter for the curved case
was located at the largest end of the tested range. Particle specific density was
explored and found to have a negligible effect. Finally, curvature and stenosis
location (superior, inferior, and ventral/dorsal) play a large role in optimiz-
ing breakup position. It is optimal for the stenosis to be in the path of the
aggregate particle.
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1 Introduction
Every year in the United States 795,000 people suffer from a stroke, which is a gov-
erning cause of long-term disability and the fifth leading cause of death in the coun-
try [1,2]. Approximately 85% of all strokes are ischemic (blockage in blood flow), and
intracranial atherosclerosis is a leading cause of ischemic stroke [1,3]. Approximately
50% of ischemic strokes occur within the middle cerebral artery (MCA) region [1].
The MCA is positioned within a connection of several arteries located in the brain’s
inferior region known as the Circle of Willis (CoW) [4]. Plaque formation within the
CoW is primarily consigned to its large arteries which includes the MCA [3].
In addition to the prevalence of strokes, a connection between strokes and other
disease necessitates research into medical prevention measures. Intracranial atheroscle-
rosis and ischemic stroke are also risk factors to the development of dementia [3]. A
link has been established between atherosclerosis within the CoW and Alzheimer’s
Disease [5]. Hypoperfusion due to CoW plaques could be the contributing factor,
as considerable widespread pathologic hemodynamic changes in the brain have been
observed in Alzheimer’s Disease patients [5]. This seems reasonable considering the
CoW supplies 80% of the oxygenated blood to the cerebrum, whose functions include
reasoning and problem solving [1].
Antithrombotic therapy, risk factor modification, and lipid-lowering treatments,
along with more invasive stenting and bypass surgeries, are all currently being used to
treat intracranial atherosclerosis [6]. Apart from healthy lifestyle changes, all of these
treatments are not without their risks and most do not attempt to remove plaque
from arteries. Among the noninvasive treatments, antithrombotic therapy, the use
of an antiplatelet or anticoagulant to reduce clotting, comes at the risk of increased
bleeding [7]. Lipid-lowering treatments use statins to lower overall cholesterol to slow
down the buildup of plaques with possible risk of liver damage and development of
type II diabetes [8].
A therapy that is effective in dissolving plaque from arteries is necessary for treat-
ing patients at risk of experiencing a stroke. Targeted nanotherapeutics have increas-
ingly been developed and used to dissolve malignant tumors [9]. Specifically targeted
nanotherapeutics that take advantage of mechanical forces may be a novel method
to attack atherosclerosis in the future. Thrombosed vasculature displays mechanical
characteristics which differ from normal blood vessels. In a thrombosed vasculature,
the local fluid shear stress (caused mainly by friction) may increase greatly, from
under 70 dyne/cm2 to greater than 1,000 dyne/cm2 (1 dyne = 1× 10−5 N) [10].
The high fluid shear stress in these locally stenosed regions activates platelets
which quickly adhere to the vessel, causing narrowing. Activation of platelets through
high fluid shear stress is a major contributing factor to the development of atheroscle-
rotic plaques. Korin et al., as described in their 2012 paper, developed a shear stress
activated nano-therapeutic (SA-NT) inspired by platelet shear stress activation to
target atherosclerotic plaques [10]. The therapeutic consists of particles that are ap-
proximately the size of platelets, between one and five micrometers in diameter. Each
particle is an aggregate consisting of smaller nanoparticles. The therapeutic remains
intact during normal flow conditions but breaks up into their smaller components
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when exposed to higher levels of fluid shear stress. These smaller nanoparticles will
experience lower drag forces and consequently have greater adherence to the stenosis
allowing the therapeutic to be locally targeted and dissolve the atherosclerosis.
These SA-NTs are constructed by spray-drying solutions of poly-lactic-co-glycolic
acid (PLGA) to form a micrometer sized aggregate composed of smaller nanoparticles.
Most other current therapeutics work to stop plaque growth instead of dissolving it,
as the SA-NT is designed to do . The great benefit of using targeted SA-NTs is
the ability to use a much smaller dosage without compromising effectiveness. It was
shown that to clear a pulmonary embolism within mice, this method used 1/100 the
normal dose [10]. SA-NTs, in conjunction with temporary endovascular bypass, have
been shown to achieve high rates of recanalization without the dangers of vascular
trauma seen in stent-retriever thrombectomies [11].
While targeting atherosclerosis with high dosage therapeutics is desirable, stud-
ies must be conducted to ensure that unwanted side effects are minimized through
effective aggregate breakup. Korin et al. determined a shear stress threshold of
100 dyne/cm2 [10]. Nanoparticles breaking off from the aggregate at this, or higher,
shear stress intensity or higher were detected at levels that are an 8-12 fold increase as
compared to the levels detected under normal shear stress conditions. Using computa-
tional fluid dynamics (CFD), they equated this shear stress level to a 60% obstructed
vessel. Normal vessels experience a typical level of shear stress of approximately
10 − 30 dyne/cm2 [10]. Aggregate particle parameters that will allow targeting of
vessels less than 60% obstructed is a practical pursuit, as narrowing of 50% to 69% is
considered moderate and may require aggressive treatment, especially if the patient
is showing symptoms of the disease [12, 13].
Numerical studies have been conducted to determine the effect of certain param-
eters of particles in the bloodstream, which aid in drug development. These parame-
ters were primarily studied to give insight to particle binding which may contribute
to the retention of large amounts of toxic particles. Doig et al. studied the influence
of particle size compared to average particle residence time in a bifurcated carotid
artery using numerical methods [9]. Using an arterial geometry with a diameter of
approximately 0.34 cm, the conclusion was that particle size and mean residence time
are positively correlated, with the maximum residence time dropping sharply with a
reduction in particle size. However, as the particle diameter decreased, the number
of particles experiencing wall interactions increased. The test was also run for an
arteriole geometry with a diameter of approximately 0.0034 cm . The smaller size
allowed Brownian motion to be a larger factor, and the residence time increased by
3% when reducing the particle size from 500 nm to 50 nm [9].
Studies concentrating on SA-NTs and how different parameters influence their
breakup have not yet been fully conducted. Additionally the applicability of SA-NTs
in the treatment of atherosclerosis in the CoW is not fully understood [10]. The roles
that particle density, particle diameter, vessel geometry, stenosis shape, and breakup
threshold (shear rate) play in the effectiveness of SA-NTs have not been studied
extensively. This study seeks to investigate these parameters and their influence
on aggregate breakup position and rate using numerical modeling techniques. For
SA-NTs to work as intended, enough of the aggregate must break up at the stenosis.
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Breakup before or after will not be effective in treating atherosclerosis and could have
potentially harmful effects. We will explore the effect of the parameters on breakup
position and rate using several idealized arterial geometries. Each geometry will have
one of three curvatures and either a concentric or eccentric stenosis.
2 Methods
The computational method involves a number of steps, which we now broadly de-
scribe. Details of each step are described in the subsections which follow. The
numerical simulations begin by creating idealized arterial geometries. Flow data,
in the form of a velocity field, is then calculated using the Navier-Stokes equation
for each geometry. A force balance equation is solved using a combination of inves-
tigated parameters to determine particle trajectories. The aggregate particle model
consists of twenty-five nanoparticles attached to the surface of each aggregate particle.
Each nanoparticle has an 1.8× 10−5 cm diameter which matches the diameter of the
nanoparticles in Korin, et al.’s 2012 paper [10]. Once a breakup threshold has been
met, in this case once the particle reaches a certain angular velocity, the aggregate
particle will break up and its components are tracked as they disperse through the
flow. Figure 1 outlines the computation method.
A total of seven arterial geometries were evaluated. These seven are idealized ge-
ometries, with each possessing one of three curvatures. All of the idealized geometries
represent a vessel with a diameter of 0.5 cm and a length of 7.0 cm. The flow enters
each geometry in a single inlet and exits using a single outlet. Geometry curvatures
are either a straight pipe (R1), a 7.0 cm segment of a 44.56 mm radius torus, i.e., a
quarter of a torus (R2), or a 7.0 cm segment of a 22.28 mm radius torus, i.e., a half of
a torus (R3). Concentric or eccentric (off-center with respect to width) stenoses were
created within the center (with respect to length) of each geometry. For the R1 and
R3 vessels, a unique geometry with 50% occlusion (0.25 cm opening) was created for
each combination of stenosis characteristics (concentric or eccentric; and occlusion).
In the eccentric R3 case, superior, inferior, and ventral/dorsal locations also are stud-
ied. Figure 2 shows a selection of the arterial geometries and Table 1 gives a listing
of all idealized geometries tested. The inclusion of concentric and eccentric stenoses
is due to their dual prevalence in the CoW. One study of 1,220 CoW segments found
Figure 1: Overview of the computational method.
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Figure 2: Idealized Geometries. (a) R1 geometry with concentric 50% occlusion. (b)
R2 geometry with concentric 50% occlusion. (c) R3 geometry with concentric 50%
occlusion. The remaining (d,e, and f) images show the R3 geometry with eccentric
stenosis in the (d) superior, (e) inferior, and (f) ventral/dorsal locations.
that 79% of advanced plaques were eccentric and 19% were concentric. The other
2% were completely occluded plaques [3]. All seven idealized geometries were created
using FreeCAD software version 0.18 and used a .stl file for CFD analysis to assess
blood flow data [14].
2.1 Computational Fluid Dynamics (CFD) Analysis
We triangulate the idealized geometries using in-house software for segmentation/model
construction (ZMD). Each model is then used as a surface to generate a finite ele-
ment grid based on an advancing front method. The method uses in-house software
(GEN3D) to re-triangulate the surface and generate tetrahedral elements [15, 16].
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Number Vessel Geometry Stenosis Shape Stenosis Location
1 R1 Concentric NA
2 R1 Eccentric NA
3 R2 Concentric NA
4 R3 Concentric NA
5 R3 Eccentric Inferior
6 R3 Eccentric Superior
7 R3 Eccentric Ventral / Dorsal
Table 1: Overview of the vessel geometries, stenosis shapes, and stenosis locations
that were tested.
Unsteady Navier-Stokes equations are used to model blood flow with Newtonian
fluid properties (density, ρ = 1.105 g/cm3 and viscosity, μ = 0.04 Poise). The
equations are as follows:




+ v · ∇v) = −∇P + μ∇2v, (2)
where v is the flow velocity. The unsteady flow equations are solved with in-house
software that utilizes a fully implicit scheme and efficient solution algorithms (FE-
FLO) [17,18]. A traction-free boundary condition at the outlet is implemented. Ves-
sel wall compliance (ability to distend) is neglected for this study and thus, no-slip
boundary conditions are imposed at the walls.
2.2 Particle Trajectories
To attain aggregate and nanoparticle position as well as translational and rotational
(angular) velocities, a force balance equation was used. Using Newton’s 2nd law




= FAM + FB + FD + FL, (3)
where S is the specific density of the particle (ratio of particle density and fluid
density) , dvp
dt
is the acceleration of the particle, FAM is the force of added mass, FB
is the Bassett force, FD is the drag force and FL is the lift force [19]. Substitution of





















|u− vp|(u− vp) + flift, (4)




is the material derivative, u is the velocity field, CD is the coefficient of drag,
D is the diameter of the particle, | · | denotes the magnitude of the vector, flift:shear
is the shear-induced lift force and flift:rotational is the rotation-induced lift or “Magnus
force”.
This force balance equation is solved using the second-order Runge-Kutta method
(midpoint method). This technique approximates the solution of the second-order
Taylor expansion without needing to compute derivatives of f(t, y). After aggregate
breakup, each nanoparticle is also governed by Brownian motion due to its small size
and thus, we add motion in the form of a scaled pseudo-random vector to the position
of each nanoparticle.
2.3 Interpolation of Flow Data
The CFD analysis produces flow data at every 0.01 seconds. It generates 100 snap-
shots of flow data including flow velocities and pressures for each cardiac cycle of 1
second. In order to reduce our computational costs for the CFD analysis, the flow
data is interpolated into smaller time step sizes.
The binary output files are quite large, ranging from approximately 10 MB to
40 MB. This file size made it prudent to develop code to interpolate the flow data
within the model rather than creating larger output files. The time step size for the
simulation of particle trajectories is determined by a convergence test, which will be
discussed in the results section.
The subroutine interpolates the data linearly using




u = u0 + (t− t0)u1 − u0
t1 − t0 , (7)
where u = (u, v, w) and t are the interpolated velocity and time respectively, u0 =
(u0, v0, w0), and t0 are the velocities and time from an output file, and u1 = (u1, v1, w1),
and t1 are the velocities and time from the preceding output file, s is the number of
interpolated data points between two original data points, and {i ∈ Z|1 ≤ i ≤ s}.
The appropriate time step was computed from the convergence test to be 0.002 of
the original 0.01 seconds. This algorithm does not store any of the interpolated data
after each iteration in order to minimize computer memory usage.
2.4 Initial Conditions
Aggregate particles are allocated every 50 elements on a plane 0.05 cm from the geom-
etry inlet. The number of elements between aggregate particles was chosen arbitrarily.
The number of aggregate particles in the test and their position is dependent on the
number of triangular elements that make up the inlet. This method produces between
10 and 20 particles for each geometry. After aggregate particles break up into their
nanoparticle components the aggregate particle is still tracked in the flow as if it had
not broken up for the possibility of gaining further insight.
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2.5 Particle Ricochet Assumption
The computational method allows particles to exit the geometry at any point in a
cycle. Therefore, a method had to be devised to prevent a particle, aggregate or
nano-, from leaving the domain through the arterial vessel wall. We assume that a
particle hitting the vessel walls is bounced back to the luminal region so that: 1) the
particle motion obeys the linear momentum conservation law by considering the walls
are rigid and 2) there are no biochemical reactions between the walls and particle.
To ensure that particles do not leave the geometric domain prematurely, we have
developed a ricochet method that enables particles to exit the outlet.
If v is the incident vector, n̂ is the normal vector to the surface at the point at
which v hits, then the reflected vector w is described by
w = 2n̂(v · n̂)− v. (8)
The reflected vector has an angle of reflection that is the same as the angle of inci-
dence.
If a particle leaves the geometry domain but did not exit through the geometry
outlet during a time step iteration, the algorithm creates a line between the particle’s
position at the previous time step and the particle’s current position outside the do-
main. This line consists of 100,000 equally spaced points. The geometric boundaries
used in our study are comprised of triangular elements. The centroid (geometric cen-
ter) of each triangular element and the distance between every point on the created
line and every element’s centroid is calculated, and the minimum distance is deter-
mined. The centroid with the minimum distance from the line is then used to create
a unit normal from the surface. Vector v is then calculated by finding the component
wise distance from the original position (x1, y1, z1) to the centroid and normalized
Figure 3: Geometry of the particle ricochet subroutine. The particle (position 1) has
moved outside the domain to position 2. This routine moves the particle back into
the domain to a point (position 3) of reflection off the boundary.
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by its magnitude. The reflection vector is scaled by the distance from the geometry
surface to the particle’s current position outside the domain (x2, y2, z2). Vector w is
calculated using Eq. 8, scaled, and added to the centroid vector to determine the new
position of the particle.
2.6 Convergence Test
A convergence test was performed to determine a time step at which the discretiza-
tion error is minimal. A straight arterial vessel with diameter of 0.5 cm and length
of 7.0 cm was used as the geometry for this test. It contained a concentric stenosis
at its center with a maximum narrowing of 0.25 cm. Eighteen particles were simul-
taneously tracked, each having a different arbitrary starting position. This test was
performed eleven times, starting with the original time step from the binary flow data
of 0.01 seconds and dividing that time step in half for each study thereafter. For each
particle, the radial position data was collected from each study. Figure 4 shows the
convergence test of a single aggregate particle moving through the R1 geometry with
50% occlusion.
A comparison of particle position for each particle every 0.01 seconds was made
between each consecutive study. The maximum difference between position data
was calculated and normalized using the geometry’s radius of 0.5 cm. Using an
error threshold of 0.001, it was determined that the difference between study 10
(0.01 s/512) and study 11 (0.01 s/1024) met the convergence threshold requirements
for all particles except one (MP8). It was observed that the majority of maximum
position differences were located near the outlet of the geometry. Since this study
Figure 4: Convergence test of a single aggregate particle moving through R1 geometry
with concentric 50% occlusion.
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is concerned with the region around the stenosis it was sensible to define a stenosis
region and restrict the data analysis to it. The stenosis region is defined as being 1.5
cm before and after the center of the stenosis at 3.5 cm from the inlet. Tables 2 and
3 compare the maximum position with all data and the maximum position contained
around the stenosis.
From 2.0 cm to 5.0 cm from the inlet, all particles met the threshold requirement
between study 10 and 11. Therefore 0.01/512 was determined to be the time step for
this model. We use the time step for the rest of our simulations. In conducting the
convergence study an interesting correlation was found between initial radial position
of the aggregate particle and the normalized maximum difference between position
data of the dt/512 versus dt/1024 case. It appears that particles positioned farther
away from the stenosis center had a greater gap between the dt/512 and dt/1024
cases, as seen in Figure 5.
Study 1 2 3 4 5 6 7 8 9 10
Data Set 1 Original DT/2 DT/4 DT/8 DT/16 DT/32 DT/64 DT/128 DT/256 DT/512
Data Set 2 DT/2 DT/4 DT/8 DT/16 DT/32 DT/64 DT/128 DT/256 DT/512 DT/1024
Particle Normalized Δr
1 9.03E-02 2.71E-02 2.24E-02 1.29E-02 1.00E-02 4.90E-03 2.39E-03 1.29E-03 6.07E-04 9.83E-04
2 6.85E-02 3.05E-02 2.49E-02 1.48E-02 7.73E-03 4.90E-03 2.72E-03 1.90E-03 9.65E-04 4.91E-04
3 1.81E-01 4.36E-02 3.05E-02 1.70E-02 9.13E-03 6.19E-03 3.32E-03 2.56E-03 1.61E-03 8.13E-04
4 5.33E-02 5.68E-02 3.19E-02 1.79E-02 8.26E-03 3.80E-03 1.83E-03 8.99E-04 6.46E-04 3.65E-04
5 2.05E-02 1.12E-02 6.62E-03 3.42E-03 1.79E-03 9.27E-04 4.68E-04 2.37E-04 1.21E-04 5.99E-05
6 1.39E-02 1.03E-02 5.78E-03 2.95E-03 1.47E-03 7.34E-04 3.77E-04 1.90E-04 9.48E-05 4.59E-05
7 5.15E-02 6.04E-02 3.37E-02 1.68E-02 7.86E-03 3.87E-03 1.88E-03 9.16E-04 4.62E-04 2.34E-04
8 1.58E-01 3.13E-02 4.02E-02 2.12E-02 4.42E-02 3.56E-02 1.33E-02 5.65E-03 3.83E-03 1.54E-03
9 6.12E-02 5.74E-02 3.68E-02 1.88E-02 9.39E-03 4.60E-03 2.31E-03 1.19E-03 6.52E-04 2.98E-04
10 2.40E-02 1.38E-02 7.30E-03 4.10E-03 2.17E-03 1.06E-03 5.26E-04 2.67E-04 1.36E-04 7.45E-05
11 1.03E-02 5.12E-03 3.22E-03 1.63E-03 8.10E-04 4.15E-04 2.08E-04 1.05E-04 5.16E-05 2.64E-05
12 2.24E-02 1.14E-02 6.30E-03 3.41E-03 1.73E-03 8.89E-04 4.46E-04 2.24E-04 1.12E-04 5.73E-05
13 7.69E-02 7.06E-02 3.51E-02 2.05E-02 9.92E-03 5.15E-03 2.46E-03 1.24E-03 6.08E-04 3.08E-04
14 1.07E-01 6.20E-02 3.07E-02 3.52E-02 1.87E-02 8.85E-03 3.87E-03 1.88E-03 8.86E-04 4.34E-04
15 8.02E-02 2.71E-02 3.72E-02 2.42E-02 1.55E-02 9.58E-03 4.74E-03 2.90E-03 1.43E-03 7.35E-04
16 5.71E-02 3.49E-02 1.98E-02 1.26E-02 5.73E-03 3.02E-03 1.49E-03 7.51E-04 3.77E-04 1.86E-04
17 9.08E-02 5.80E-02 2.98E-02 1.57E-02 7.56E-03 3.66E-03 1.82E-03 8.96E-04 4.48E-04 2.32E-04
18 1.50E-01 2.46E-02 2.81E-02 2.54E-02 1.17E-02 7.01E-03 3.50E-03 1.72E-03 8.56E-04 4.25E-04
Table 2: Convergence Test: Normalized Δr by study (all data). Cells highlighted in
blue meet the threshold requirement.
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Study 1 2 3 4 5 6 7 8 9 10
Data Set 1 Original DT/2 DT/4 DT/8 DT/16 DT/32 DT/64 DT/128 DT/256 DT/512
Data Set 2 DT/2 DT/4 DT/8 DT/16 DT/32 DT/64 DT/128 DT/256 DT/512 DT/1024
Particle Normalized Δr
1 9.03E-02 2.71E-02 2.20E-02 9.04E-03 4.79E-03 2.25E-03 1.01E-03 5.06E-04 5.88E-04 9.83E-04
2 6.85E-02 2.08E-02 2.48E-02 1.48E-02 7.73E-03 4.23E-03 2.07E-03 1.06E-03 5.26E-04 2.64E-04
3 1.81E-01 4.29E-02 3.05E-02 1.70E-02 9.13E-03 4.73E-03 2.52E-03 1.28E-03 6.45E-04 3.17E-04
4 5.33E-02 4.23E-02 2.32E-02 1.37E-02 6.57E-03 3.17E-03 1.55E-03 7.75E-04 3.86E-04 1.90E-04
5 2.05E-02 1.05E-02 6.16E-03 3.38E-03 1.79E-03 9.27E-04 4.68E-04 2.37E-04 1.21E-04 5.35E-05
6 1.39E-02 1.03E-02 5.78E-03 2.95E-03 1.30E-03 6.38E-04 3.28E-04 1.63E-04 8.14E-05 3.96E-05
7 5.15E-02 4.66E-02 2.56E-02 1.38E-02 6.70E-03 3.34E-03 1.65E-03 8.13E-04 4.09E-04 2.10E-04
8 1.58E-01 3.13E-02 4.02E-02 2.12E-02 1.16E-02 5.63E-03 2.82E-03 1.40E-03 7.04E-04 3.71E-04
9 6.12E-02 4.88E-02 3.24E-02 1.79E-02 9.12E-03 4.60E-03 2.31E-03 1.14E-03 5.73E-04 2.92E-04
10 2.40E-02 1.35E-02 7.03E-03 3.91E-03 2.02E-03 9.88E-04 4.92E-04 2.49E-04 1.27E-04 7.45E-05
11 1.03E-02 5.12E-03 3.00E-03 1.57E-03 7.61E-04 3.90E-04 1.96E-04 9.88E-05 4.86E-05 2.46E-05
12 2.24E-02 1.14E-02 6.30E-03 3.34E-03 1.69E-03 8.64E-04 4.34E-04 2.18E-04 1.09E-04 5.43E-05
13 7.69E-02 6.59E-02 3.31E-02 1.99E-02 9.79E-03 5.15E-03 2.46E-03 1.24E-03 6.08E-04 3.08E-04
14 9.47E-02 6.20E-02 3.07E-02 2.06E-02 1.35E-02 6.28E-03 2.98E-03 1.43E-03 7.33E-04 3.33E-04
15 8.02E-02 2.71E-02 3.72E-02 2.11E-02 1.17E-02 5.71E-03 2.79E-03 1.39E-03 7.37E-04 3.67E-04
16 5.30E-02 2.95E-02 1.59E-02 9.21E-03 4.24E-03 2.31E-03 1.15E-03 5.79E-04 2.89E-04 1.42E-04
17 8.21E-02 4.88E-02 2.51E-02 1.38E-02 6.83E-03 3.39E-03 1.70E-03 8.36E-04 4.19E-04 2.20E-04
18 1.45E-01 2.46E-02 2.81E-02 2.02E-02 1.08E-02 5.43E-03 2.68E-03 1.30E-03 5.65E-04 2.83E-04
Table 3: Convergence Test: Normalized Δr by study (stenosis region). Cells high-
lighted in blue meet the threshold requirement.
Figure 5: Convergence test showing the positive correlation between initial radial




3.1 Optimal Breakup Threshold
Angular velocity, ω, was used as a breakup threshold for aggregate particles. When
the aggregate particles reach an angular velocity threshold, they break up into their
nanoparticle components. Once an aggregate particle is broken, the twenty five
nanoparticles will break off with the same velocity and angular velocity as the aggre-
gate particle had just prior to breakup as shown in Figure 6. To determine a breakup
threshold, the angular velocity at time step, t = 1, was calculated for each aggre-
gate particle. The minimum angular velocity, ωmin, was determined, and different
breakup thresholds were generated by scaling ωmin to a variety of magnitudes. To
determine the optimal breakup threshold for each study, two criteria were measured:
the percentage of particles that broke up within the stenosis region and the average
distance the aggregate particle broke up from the center of the stenosis. This aver-
age includes all aggregate particles, including those that did not break up within the
stenosis region as well as those that broke up before and after the stenosis.
For the R1 and R3 geometries, we chose the stenosis region to be 1 cm before
and 1 cm after the center of the stenosis along the z-axis. This a slightly smaller
region than the region used in our original convergence test. The stenosis region
on the R2 geometry consisted of the area spanning 0.5 cm before and 0.5 cm after
the center of the stenosis. The shorter region is due to the stenosis lying on a slant
relative to the z-axis. The average breakup distance from the center of the stenosis
was ascertained by capturing the position of the first appearance of a nanoparticle
from each aggregate particle. Due to time and post processing limitations, data from
Figure 6: Aggregate particle breakup into nanoparticle components.
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Figure 7: Radial position as a function of position along the z-axis for aggregate
particles flowing through the concentric R1 vessel geometry with an optimal breakup
threshold. The stars (*) indicate particle breakup position. Note that aggregate
particles continue to be tracked through the flow as though they never broke apart
even if they do breakup.
every fifth time step was captured. No biochemical nanoparticle binding components
were used in this study to determine if the nanoparticles will adhere to the stenosis
after breakup.
The R1, R2 and R3 geometries with a concentric stenosis and 50% occlusion were
tested. The specific density and aggregate particle diameter were kept constant at
1.0 and 3.8 μm, respectively. An aggregate particle diameter of 3.8 μm was chosen
for consistency with Ref. [10].
For the R1 geometry, fifteen aggregate particles were inserted into the flow to
study the effect of different breakup thresholds. Thirteen different breakup thresh-
olds, determined by scaling ωmin = 14.89 rad/s for this R1 geometry, were tested
to determine the optimal value. All aggregate particles broke up within the stenosis
region when the threshold value was between 3ωmin (44.66 rad/s) and 5ωmin (74.44
rad/s). At thresholds less than 3ωmin (44.66 rad/s) particles broke up prematurely,
while at thresholds greater than 5ωmin (74.44 rad/s) particles did not break up. By
comparing the average distance of particle breakup from the stenosis center, the opti-
mal breakup threshold was determined to be 3ωmin (44.66 rad/s) as seen in Figure 7.
This breakup threshold yielded the closest average distance from the stenosis center
(0.29 cm), with all particles breaking up after the stenosis center. Table 4 shows the
results for all thirteen breakup thresholds that were tested.
It was observed that the initial particle position was correlated with the proximity
of the breakup position to the stenosis center. To ensure this observance was not an
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Figure 8: Breakup distance from stenosis center versus initial radial position of the
aggregate particle for the concentric R1 geometry. The line of best fit shows a negative
correlation, and is represented by ŷ = 0.96− 9.49r0 with an R2 value of 0.90.
Shear Threshold (ω) Total AP Total Broken AP Total Broken in Stenosis Region Avg Distance from Center (cm)
37.22 15 15 4 1.777
40.32 15 15 12 0.915
43.18 15 15 13 0.701
44.66 15 15 15 0.292
46.15 15 15 15 0.294
46.52 15 15 15 0.304
55.83 15 15 15 0.347
65.13 15 15 15 0.413
74.44 15 15 15 0.466
93.05 15 13 13 0.498
111.66 15 11 9 0.564
148.88 15 6 5 0.673
223.32 15 0 0 -
Table 4: Breakup threshold data for the R1 geometry. Note that the shear threshold
values are computed using multiples of ωmin = 14.8879598 and then rounded to two
decimals.
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error caused by recording the data at every 5th time step (as opposed to recording the
data at every time step), the simulation for the R1 geometry was repeated, this time
recording the data at every time step. The least squares linear regression analysis
was performed to determine the relationship between the initial radial position of the
particle and the proximity of the breakup to the stenosis center. For this analysis the
optimal threshold (44.66 rad/s) was used with aggregate particles possessing a 3.8 μm
diameter and specific density of 1. The line of best fit that emerged from the analysis
is given as ŷ = 0.96− 9.49r0, with an R2 value of 0.90, and where ŷ is the predicted
breakup proximity (cm) to the stenosis center, and r0 is the initial radial particle
position. The initial radial position of the aggregate particles is negatively correlated
with distance from the breakup position to the stenosis center. As particles are
placed into the flow, the farther their initial radial distance is from the geometry
center, the closer the breakup occurs to the stenosis center as seen in Figure 8.
For the R2 geometry, seventeen aggregate particles were inserted into the flow to
study the effect of different breakup thresholds. Thirteen different breakup thresh-
olds, determined by scaling ωmin = 5.90 rad/s for this R2 geometry, were tested to
determine the optimal value. All aggregate particles broke up within the stenosis re-
gion when the threshold value was between 23ωmin (135.79 rad/s) and 49ωmin (289.1
rad/s). The average distance from the stenosis center was minimized for 289.1 rad/s
at 0.10 cm from the center. All but one particle broke up before the stenosis center,
which is a stark difference to the R1 geometry in which all particles broke up after the
stenosis center. A similar regression analysis of initial radial position and breakup
position that was completed for the R1 geometry was conducted. However, unlike
the R1 geometry, no correlation was discovered in the curved R2 geometry. Table 5
shows the results for all thirteen breakup thresholds that were tested.
For the R3 geometry, ten aggregate particles were inserted into the flow to study
the effect of different breakup thresholds. Thirteen different breakup thresholds,
determined by scaling ωmin = 16.38 rad/s for this R3 geometry, were tested to de-
termine the optimal value. The maximum number of aggregate particles which broke
up within the stenosis region was nine, and occurred when the threshold value was
between 10ωmin (163.84 rad/s) and 12ωmin (196.61 rad/s). No distinct character-
istics of the tenth particle were observed. The average distance from the stenosis
center was minimal at a threshold value of 12ωmin (196.61 rad/s) as shown in Figure
9. A similar regression analysis to that described previously of initial radial position
and breakup position was conducted. No correlation was discovered in the curved
R3 geometry from this analysis. In contrast to the R1 and R2 geometries at their
optimal thresholds, a slight majority (60%) of aggregate particles broke up before the
stenosis center in the R3 geometry. Table 6 shows the results for all thirteen breakup
thresholds that were tested.
In summary, the curvature of vessel geometry greatly effects the optimal aggregate
particle breakup threshold. The optimal breakup threshold of the R2 was approxi-
mately 6.3 times greater than R1, and the R3 curved geometry was approximately
4.5 times greater than that of the R1 straight geometry. A clear correlation between
vessel curvature and optimal breakup threshold was not observed, but it can be said
that curvature creates greater complexity, which this study cannot examine fully.
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Shear Threshold (ω) Total AP Total Broken AP Total Broken in Stenosis Region Avg Distance from Center (cm)
44.28 17 17 1 0.992
59.04 17 17 4 0.848
118.08 17 17 9 0.489
121.03 17 17 15 0.221
123.98 17 17 16 0.211
129.89 17 17 16 0.184
135.79 17 17 17 0.150
141.70 17 17 17 0.145
177.12 17 17 17 0.129
283.39 17 17 17 0.104
289.30 17 17 17 0.103
295.20 17 16 16 0.097
324.72 17 16 16 0.097
Table 5: Breakup threshold data for the R2 geometry. Breakup threshold data for
the R2 geometry. Note that the shear threshold values are computed using multiples
of ωmin = 5.9040012962963 and then rounded to two decimals.
Shear Threshold (ω) Total AP Total Broken AP Total Broken in Stenosis Region Avg Distance from Center (cm)
40.96 10 10 0 2.108
122.88 10 10 4 1.347
147.46 10 10 7 0.584
163.84 10 10 9 0.445
165.48 10 10 9 0.445
175.31 10 10 9 0.482
176.95 10 10 9 0.482
178.58 10 10 9 0.481
180.22 10 10 9 0.488
196.61 10 10 9 0.364
212.99 10 8 8 0.157
245.76 10 6 6 0.143
327.68 10 6 6 0.121
Table 6: Breakup threshold data for the R3 geometry. Breakup threshold data for
the R3 geometry. Note that the shear threshold values are computed using multiples
of ωmin = 16.3839233 and then rounded to two decimals.
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The optimal breakup thresholds for both curved cases was at the highest end of the
optimal range of thresholds, while the straight case threshold was found at the lower
end of its range. It was discovered that for the straight case, a negative correlation
exists between initial aggregate particle radial position and average breakup distance
from the stenosis; this pattern was not seen in the R2 or R3 curved cases.
Figure 9: Radial position as a function of position along the z-axis for aggregate
particles flowing through the concentric R3 vessel geometry with an optimal breakup
threshold. The circles indicate particle breakup position. Note that aggregate parti-
cles continue to be tracked through the flow as though they never broke apart even
if they do breakup.
3.2 Specific Density
Specific density was tested on both the R1 and R3 geometries. Aggregate particle
diameter and breakup threshold were kept constant at 3.8 μm and 10ωmin respectively.
Specific densities from 1 to 1.3 were tested. There was no change in the results for
these cases. It was determined that in order for specific density to make any noticeable
change, the specific density would have to be set to an unrealistic value of 104 or above.
3.3 Particle Diameter
The effect of particle diameter on breakup threshold was studied using the R1 and
R3 geometries, both with a 50% concentric occlusion. The specific density was kept
constant at 1. Optimal breakup threshold values of 44.66 rad/s for the R1 geometry
and 196.61 rad/s for the R3 geometry were used. Three particle diameters (1.0, 3.8
and 5.0 μm) were studied for each geometry. These diameters were chosen based
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on the diameter of natural platelets which lies between 1.0 and 5.0 μm, while 3.8
μm was included because it is the average diameter of fabricated SA-NT aggregate
particles [10].
A positive correlation between aggregate particle diameter and average breakup
distance from stenosis center was discovered for the R1 geometry. Using regression
analysis, the relationship can be described by the equation ŷ = 0.292 + 0.0000887d,
with R2 = 0.99, and where d is the aggregate particle diameter (μm), and ŷ is
the predicted breakup proximity (cm) to the stenosis center. Similar analysis was
performed for the R3 geometry, and a negative correlation was found with ŷ = 0.454−
0.00272d, with R2 = 0.85.
This demonstrates that curvature matters when choosing an optimal aggregate
particle diameter. Smaller particles may be ideal for straight vessels and larger par-
ticles for a vessel with greater curvature. Overall the ranges of breakup distance for
the R1 and R3 geometries respectively were 3.55×10−4 and 1.13×10−2, so the benefit
may be marginal. The positive correlation between particle size and average particle
residence time found in Doig et al.’s study may warrant a larger aggregate particle
diameter in order to gain the binding benefit of larger nanoparticles [9]. Table 7 shows
the average distance from stenosis center for the R1 and R3 diameter cases that were
simulated.







Table 7: Aggregate Particle Diameter Data.
3.4 Stenosis Shape and Location
The R1 geometry was tested with a 50% occluded eccentric stenosis inserted into it in
order to compare it to the R1 concentric case. The minimum angular velocity for this
case was 11.66 rad/s. In order to attain a similar threshold value to the R1 concentric
case, 3.82ωmin was used to attain a threshold of 44.66 rad/s. Sixteen aggregate
particles were introduced into the flow. In this case, all particles broke up within
the stenosis region. The eccentric R1 case had an average minimum distance from
stenosis center of 0.29 cm, which is identical to the concentric case to two significant
digits.
The R3 geometry was tested with 50% occluded eccentric stenoses in three po-
sitions: superior, inferior, and ventral/dorsal. The superior case had a minimum
angular velocity of 1.23 rad/s. To meet the concentric case threshold, the minimum
was multiplied by 159.98. Twenty particles were tested, and all particles broke up
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Figure 10: Position of aggregate particles flowing through R3 geometries with inferior
eccentric and superior eccentric stenoses.
within the stenosis region. The average distance from the stenosis center is 0.19 cm,
which was closer than for the concentric case with the same parameters.
The inferior case had a minimum angular velocity of 2.10 rad/s. To meet the R3
concentric case threshold, the minimum was multiplied by 93.52. Twenty particles
were tested. All particles broke up within the stenosis region. The average distance
from stenosis center is 0.07 cm, which is closer than for the concentric case.
The ventral/dorsal case had a minimum angular velocity of 2.74 rad/s, and in
order to match the concentric case threshold of 196.61, the minimum was multiplied
by 71.73 to attain the threshold. Fourteen aggregate particles passed through the
flow. All particles broke up within the stenosis region, and this case had an average
distance from stenosis center of 0.20 cm, which again is closer than for the concentric
case.
In all R3 eccentric cases, the particles broke up before the stenosis center, which
agrees with the concentric case. All three eccentric cases fared better in both particle
breakup within the stenosis region and average breakup distance from stenosis center.
The inferior eccentric case performed the best due to its position relative to the
particle trajectory, reminiscent of the correlation between initial particle position and
breakup position shown in the R1 concentric case. A comparison of the inferior and
superior case are shown in Figure 10 for a visual of stenosis position and its effect on
particle trajectory. It should be noted that all eccentric cases had a greater average
particle breakup position, and all also had greater occlusion in the radial center than
the concentric case. This greater center occlusion did not seem to affect the straight
cases’ average breakup distance. Curvature, which in part drives particle trajectory,
combined with stenosis location, has a sizeable effect on optimal breakup distance.
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4 Summary and Remarks
This study used computational methods to better understand how aggregate parti-
cle breakup threshold, diameter and specific density, as well as vessel curvature and
stenosis shape affect the efficiency of shear-activated nanotherapeutics in the treat-
ment of atherosclerosis. Different idealized geometries were used to test and analyze
these parameters. Optimal angular velocity breakup thresholds were discovered for
both straight and curved geometry cases. Geometry curvature was a sizeable factor
in breakup threshold, as the curved vessel cases (R2, R3) required 6.3 and 4.5 times
the angular velocity of the straight vessel, respectively. No clear pattern was shown
relating vessel curvature and optimal breakup threshold.
In the straight geometry cases, a correlation was found between initial particle
position and particle breakup proximity to the stenosis center. As particles are po-
sitioned farther away from the vessel center, their breakup proximity from center is
decreased. A similar correlation was not found in the curved vessel cases.
Aggregate particle diameter was also explored. Diameters from 1.0 to 5.0 μm were
used for both straight and curved geometries. Small decreases in average particle
breakup distance from stenosis center were seen as particle diameters decreased for
the straight vessel case. The opposite happened with the curved vessel case. As the
particle diameter increased, a slight decrease in average particle breakup distance from
stenosis was achieved. This indicates that as vessel curvature increases, so should the
diameter of the aggregate particle for optimal results.
Different specific densities were tested for both straight and curved geometries. It
was determined that specific density will not play a role in efficiency of shear-activated
nanotherapeutics. Stenosis shape and location were tested in both the straight vessel
and one of the curved vessel geometries. Curvature in conjunction with stenosis
location had a great effect on average breakup distance from the stenosis center. This
is a similar observation to the initial particle position correlation found in the R1
cases. Both indicate that it is optimal to have the stenosis in the aggregate particle
path.
Further studies need to be conducted to find optimal parameters. Effects of greater
occlusions and more complicated geometries might give us more insight and a better
understanding of the effectiveness of shear activated nanotherapeutics. There is evi-
dence that blood viscosity is a risk factor for atherosclerosis; therefore, studies should
be conducted using greater blood viscosity than used in this study to determine its
effect on particle breakup [20].
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